RICE KENNETH L JR 3
3 · Hoth Therapeutics, Inc. · Filed Feb 15, 2019
Insider Transaction Report
Form 3
RICE KENNETH L JR
Director
Holdings
- 50,000
Common Stock
- 726,943(indirect: see footnote)
Common Stock
Footnotes (1)
- [F1]The securities are owned by Chelexa Biosciences, Inc. ("Chelexa"). Kenneth Rice is the Executive Chairman of Chelexa and in such capacity has voting and dispositive power of the securities held by such entity.